CNS Drug Reviews: Volume 11, No. 3

cns.jpg (2811 bytes)

CNS Drug Reviews

Volume 11, No. 3

Reviews
229		Cotinine, a Neuroactive Metabolite of Nicotine: Potential for Treating Disorders of Impaired Cognition Alvin V. Terry, Jr., Caterina M. Hernandez, Elizabeth J. Hohnadel, Kristy P. Bouchard, and Jerry J. Buccafusco [Abstract] [Article] [Single Reprint]
253		Ropinirole, a Non-Ergoline Dopamine Agonist Wolfgang H. Jost and Dieter Angersbach [Abstract] [Article] [Single Reprint]
273		Pharmacological Properties, Central Nervous System Effects, and Potential Therapeutic Applications of Atipamezole, a Selective α₂-Adrenoceptor Antagonist Antti Pertovaara, Antti Haapalinna, Jouni Sirviö and Raimo Virtanen [Abstract] [Article] [Single Reprint]
289		Preclinical Neuropharmacology of Naratriptan Geoffrey A. Lambert [Abstract] [Article] [Single Reprint]
317		Clinical Potential of GABA_BReceptor Modulators Jennifer Ong and David I. B. Kerr [Abstract] [Article] [Single Reprint]
MEETING REPORTS
335		Alzheimer’s Association International Conference on Prevention of Dementia. Washington, D.C. June 18–21, 2005. Alexander Scriabine [Article] [Single Reprint]
339		IBC’s 10th Annual World Congress. Drug Discovery Technology and Development 2005. Boston, MA. August 8–11, 2005. Alexander Scriabine [Article] [Single Reprint]